Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: CYTOSORBENTS MEDICAL INC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2020-09-24 to 2024-01-23
Current total value of award: $1098588.51
Description: DHA SBIR PHASE II AN91 MEDICAL R&D CONTRACT H2S-0005 (MONTHS 1-12)NCE FOR DEVELOPMENT OF AN EFFECTIVE ADSORBER TO REMOVE ANTI-A AND ANTI-B ANTIBODIES FROM PLASMA FOR TRANSFUSION